| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/17/2010 | EP2153828A2 Composition for the Transdermal Delivery of Fentanyl |
| 02/17/2010 | EP2153827A2 Composition for the Transdermal Delivery of Fentanyl |
| 02/17/2010 | EP2152321A1 Water treatment containing dbnpa for use in sanitizing recreational water |
| 02/17/2010 | EP2152312A1 Low-viscous anthracycline formulation |
| 02/17/2010 | EP2152252A2 Selective proteasome inhibitors for treating diabetes |
| 02/17/2010 | EP2152078A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 02/17/2010 | EP1581215B1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
| 02/17/2010 | EP1536781B1 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | CN101652147A Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener |
| 02/17/2010 | CN101648019A Medicinal composition for treating ophthalmic inflammation and application thereof |
| 02/17/2010 | CN101648018A Medicinal composition for treating ophthalmic inflammation and application thereof |
| 02/17/2010 | CN101648017A United medicinal composition used for treating urogenital system and lower urinary tract diseases |
| 02/17/2010 | CN101648016A Medicinal composition with high stability |
| 02/17/2010 | CN101648015A Chinese medicinal composition for treating glaucoma and application thereof |
| 02/17/2010 | CN101648014A Medicinal composition for treating skin injury and ulcer and application thereof |
| 02/17/2010 | CN100589809C Quaternised ammonium cyclodextrin compounds |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662823 non-nucleoside reverse transcriptase inhibitors; for treatment of HIV and AIDS |
| 02/16/2010 | US7662805 Mixture of antidepressant such as serotonine receptor antagonist, with acetylsalicylic acid |
| 02/16/2010 | US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 02/16/2010 | US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/16/2010 | US7662792 Modulation of Fas and FasL expression |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | US7662405 Comprises phosphatidyl choline, phosphatidyl glycerol, and cholesterol; for delivery to tumors |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 02/16/2010 | US7662366 Administering granulocyte colony stimulating factor; treating type 2 diabetes in simple, safe manner |
| 02/16/2010 | US7662365 Polymer conjugates of opioid antagonists |
| 02/16/2010 | CA2455224C Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies |
| 02/16/2010 | CA2447175C Use of estrogen compounds to increase libido in women |
| 02/16/2010 | CA2438961C Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/16/2010 | CA2371912C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/16/2010 | CA2344435C Compositions for the treatment of male erectile dysfunction |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/11/2010 | WO2010017163A1 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| 02/11/2010 | WO2010016590A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 02/11/2010 | WO2010016552A1 Therapeutic agent for irritable bowel syndrome |
| 02/11/2010 | WO2010015870A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 02/11/2010 | WO2010015827A2 Phosphate binding materials and their uses |
| 02/11/2010 | US20100036107 Rna interference compositions and methods |
| 02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035885 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100034882 Silver-containing compositions, devices and methods for making |
| 02/11/2010 | US20100034779 Compositions and methods for producing pluripotent cells from adult testis |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | US20100034774 Serotype of adenovirus and uses thereof |
| 02/11/2010 | DE202009010937U1 Monoterpene für die Behandlung von Atemwegserkrankungen, insbesondere von bronchopulmonalen Erkrankungen Monoterpene for the treatment of respiratory disorders, in particular of bronchopulmonary disorders |
| 02/11/2010 | CA2733059A1 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 02/11/2010 | CA2733057A1 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732802A1 Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732799A1 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732226A1 Phosphate binding materials and their uses |
| 02/11/2010 | CA2730715A1 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2150277A1 Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 02/10/2010 | EP2150260A2 Compositions and methods for the treatment of heart failure |
| 02/10/2010 | EP1499331B1 Salt solution for colon cleansing |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | EP1411932B1 Substituted oxazolidinones for combinational therapy |
| 02/10/2010 | CN101646460A Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient |
| 02/10/2010 | CN101646459A Chronic rejection inhibitor |
| 02/10/2010 | CN101643789A RNA interference mediating small RNA molecules |
| 02/10/2010 | CN101642571A Medicinal composition containing amlodipine, ACE inhibitor and stains |
| 02/10/2010 | CN101642570A Application of carbon monoxide-releasing molecules and heparin in preparing medicament for treating sepsis |
| 02/10/2010 | CN101642569A Usage of active natural product B for preparing antifungal and antitumor product |
| 02/10/2010 | CN101642568A Rhodiola root composition |
| 02/10/2010 | CN101642459A Combination dosage form containing a cholesterol -lowering agent, an inhibitor of the renin-angiotensin, and aspirin |
| 02/10/2010 | CN100588395C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 02/10/2010 | CN100588394C Compound tablet capable of controlling release of effective component after oral administration, and preparation method thereof |
| 02/09/2010 | US7659426 for proliferative, inflammatory diseases and an encephalopathy; non-steroidal anti-inflammatory drugs (NSAIDs); KSRP (KH-type splicing regulatory protein), |
| 02/09/2010 | US7659377 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 02/09/2010 | US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659301 Controlling photoactivation; reducing oxygen concentration of tissue at site; prevention metabolism; cooling |
| 02/09/2010 | US7659285 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 02/09/2010 | US7659257 Medicament for treating lung cancer |
| 02/09/2010 | US7658944 Gemfibrozil, fenofibrate, bezafibrate, clofibrate, ciprofibrate and active metabolites and analogues dissolved in a vehicle, which is hydrophobic, hydrophilic or water-miscible; improved bioavailability of the active ingredient upon oral administration |
| 02/09/2010 | US7658941 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/09/2010 | US7658939 Inert core, first layer comprising naltrexone, nalmefene or salts; and second hydrophobic layer; pain treatment |
| 02/09/2010 | US7658923 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/09/2010 | US7658916 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
| 02/09/2010 | CA2482320C Methods for modulating phototoxicity |
| 02/09/2010 | CA2466720C Medicament for the treatment of viral skin and tumour diseases |
| 02/09/2010 | CA2431079C Method and composition for the treatment of diabetic neuropathy |
| 02/09/2010 | CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 02/09/2010 | CA2378976C Method of controlling body temperature while reducing shivering |
| 02/09/2010 | CA2287469C Interactive system for presenting and eliminating substances |
| 02/09/2010 | CA2150933C Glaucoma treatment |
| 02/04/2010 | WO2010014957A1 Methods for treating reperfusion injuries |
| 02/04/2010 | WO2010014771A1 Romazarit for treating metabolic diseases |
| 02/04/2010 | WO2010013633A1 Methods for prediction of rb status and sensitivity to plk1 inhibitor of cell |
| 02/04/2010 | WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor |